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Abstract
Background: Systemic lupus erythematosus (SLE) is 
an autoimmune disease which involves many different 
organ systems and immunological abnormalities. SLE 
mainly affects females in their reproductive age. This 
study aimed to describe the fetal outcome, neonatal 
complications, maternal outcome, and obstetrics 
complication in patients diagnosed with SLE, in order 
to help the physicians to reduce the fetal loss, improve 
maternal morbidity, and reduce neonatal or maternal 
deaths.
Method: This research was conducted using descriptive 
quantitative design. Data were obtained from direct 
interview noted in a report form and medical records. 
Subjects were SLE patients who came to Rheumatology 
Outpatient clinic, Dr. Hasan Sadikin General Hospital, 
Bandung from September 2016 to November 2016; and 
fulfilled the inclusion and exclusion criteria. The minimal 
required sample was 96 subjects. 
Results: Due to time limitation, only 53 pregnancies 
from 40 females were managed to be recorded. The 
median age when being diagnosis of the subjects was 
24 (14 - 41) years old. The fetal outcomes showed 
64.2% live births, 18.9% spontaneous abortions, 
9.4% intrauterine death, 1.8% intrauterine growth 
retardation, and 9.1% neonatal deaths. Neonatal 
complications included premature delivery, low birth 
weight, and growth retardation. Maternal complications 
during pregnancy included rash, pregnancy-induced 
hypertension, arthritis, anemia, and thrombocytopenia. 
Furthermore, obstetric complications included 13.2% 
pre-eclampsia, 13.2% placenta previa, and 1.8% stroke. 
There were 2 cases (3.8%) of maternal death happened 
during the delivery.
Conclusion: The most frequent maternal complications 
during pregnancy were arthritis and rash. Pre-eclampsia 
and placenta previa were the most frequent obstetric 
complications which experienced by the pregnant SLE 
patients. Exclude the live births, the most frequent fetal 
outcome was spontaneous abortion. The most frequent 
neonatal complications were preterm delivery and low 
birth weight. 
Keywords: pregnancy, systemic lupus erythematosus, 
fetal outcomes, maternal outcomes
Introduction
Systemic lupus erythematosus (SLE) is a systemic 
autoimmune disease which characterized by 
heterogeneous, multi organ system involvement, 
and the production of the arrays of autoantibodies.1 
A 9:1 female-to-male ratio has been reported with 
peak age of onset between 15 and 40 years old.2 
The disease is dominantly affected women in their 
reproductive years.3 However, women with SLE 
have the same fertility as the healthy women with 
the same age.4 In the past, women with SLE were 
advised not to get pregnant due to poor fetal and 
maternal outcomes and also due to high tendency 
of flare-up.5 
The relationship of SLE with pregnancy is 
complex. Female SLE patients would suffer from 
dilemma of their desire to get pregnant and the 
difficulties of managing lupus during pregnancy. 
Study reported women with active lupus at the 
onset or in the early stages of pregnancy have 
high rate of pregnancy loss.6 Moreover, there is an 
increased risk of spontaneous abortions, premature 
births, intrauterine growth retardation and stillbirth 
in overall SLE pregnancy.7 Therefore, the outcome 
of pregnancy become a major concern in most SLE 
patients.8 
The maternal complications faced by the SLE 
patients during pregnancy include hypertension, 
lupus flare, lupus nephritis, arthritis, pre-eclampsia, 
and more severe complications such as eclampsia, 
HELLP (hemolysis, elevated liver enzymes, low 
platelets) syndrome, stroke, and maternal death.9 
Neonates from an SLE mother has higher risk to 
develop neonatal lupus erythematosus (NLE) 
that could result in cardiac, dermatologic, hepatic 
disorders, and hematologic abnormalities.10 
Congenital heart block is also one of the major 
complications which is occured in 2% of neonates 
from SLE mother. Congenital heart block is an 
irreversible condition which causes the scarring 
of the cardiac tissue and eventually affects the 
functionality of the heart.11
There is no data about the outcome of pregnancy 
in patients with SLE in Indonesia and in Dr. Hasan 
Sadikin Hospital. The objective of our research 
was to describe the fetal and maternal outcome 
and complications in pregnancy with SLE in order 
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to help the physicians to reduce the maternal morbidity or 
mortality and fetal loss.
Method
This research was conducted using descriptive quantitative 
design. Data was collected from medical records and noted 
in a report form. Subjects were female SLE patients visited 
Outpatient Rheumatology clinic of Dr. Hasan Sadikin Hospital 
between September 2016 to November 2016. An ethical 
clearance letter was obtained from the Ethical Clearance 
Committee of Faculty of Medicine Universitas Padjadjaran 
before the study proceeded.
The minimum required sample for this study were 96 
cases. The inclusion criteria was female SLE patients who had 
at least one pregnancy at or after she was diagnosed as SLE. 
SLE was diagnosed with America College of Rheumatology 
Criteria 2010.12 Patients who were unwilling to follow the 
study or do not remember the history of their pregnancy 
were excluded from the study. After the selection, subjects 
were required to sign an informed consent form regarding the 
objectives and procedure of the test. 
The report form comprised of the questions about the basic 
information, gestation history, fetal and maternal outcome, and 
lastly, neonatal and obstetrics complications of the subjects. 
Data were analyzed descriptively using Microsoft Excel 2012.
Results
We only gathered 53 pregnancies cases from 40 female SLE 
patients were due to time limitation. The characteristics of 
subjects were presented in Table 1.
Table 1. Characteristics of the subjects.
Characteristics Result
Age of Diagnosis (years) 24 (14-41)*
Present Age (years) 31.5 (24-47)*
Duration of the disease (years) 6.5 (0-17)*
*not normally distributed data, data presented in median (range)
Table 1 above shows the median age when diagnosis made 
was 24 years old, demonstrating that SLE mainly affects 
female in their reproductive years.
Chart 1. Maternal Complications of SLE patients.
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The results of maternal complications occurred during pregnancy are shown in Chart 
1. Arthritis presented to be the highest frequency of maternal complication and followed by 
rash. Most patients experienced complications during their 2nd pregnancy.
Table 2. Obstetrics Complication and Maternal Outcome of SLE patients.
Obstetric Complication, N=40 Result, N (%)
Maternal mortality 2 (3.8%)
Stroke 1 (1.8%)
Pre-eclampsia 7 (13.2%)
Placenta previa 7 (13.2%)
According to Table 2, 13.2% of the pregnant SLE patients experienced pre-
eclampsia and placenta previa during birth. Maternal mortality presented with 2 cases. 
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The results of maternal complications occurred during 
pregnancy are shown in Chart 1. Arthritis presented to be the 
highest frequency of maternal complication and followed by 
rash. Most patients experienced complications during their 2nd 
pregnancy.
Table 2. Obstetrics Complication and Maternal Outcome
 of SLE patients.
Obstetric Complication, N=40 Result, N (%)
Maternal mortality 2 (3.8%)
Stroke 1 (1.8%)
Pre-eclampsia 7 (13.2%)
Placenta previa 7 (13.2%)
 
According to Table 2, 13.2% of the pregnant SLE patients 
experienced pre-eclampsia and placenta previa during birth. 
Maternal mortality presented with 2 cases. 
Table 3. Fetal outcomes in SLE pregnancy.
Fetal outcome, N=53 cases Result, N (%)
Live born 34 (64.2%)
Spontaneous abortion 10 (18.9%)
Intrauterine death 5 (9.4%)
IUGR* 1 (1.8%)
Neonatal mortality 3 (5.7%)
*IUGR= Intrauterine Growth Retardation
Table 3 recorded the results of fetal outcome and neonatal 
complications of our study. Based on the table, out of the 53 
pregnancies had more than half live births. However, there are 
still highlight cases of abortion in 18.9%. 
Table 4. Neonatal Complications.
Neonatal complication, N=34 cases Result, N (%)
Preterm Delivery 10 (29.4%)
Low Birth Weight 14 (41.2%)
Growth retardation 1 (2.9%)
Neonatal Lupus 0
Congenital Heart Block 0
  
Table 4 shows that the most frequent neonatal complications 
were preterm delivery and low birth weight. 
Discussion 
Based on our results, arthritis (35.8%) presented to be the 
most common flares during the subjects’ pregnancy period, 
following by rashes (28.3%). Same amount of subjects 
experienced pre-eclampsia (13.2%) and placenta previa 
(13.25) when they were giving birth. Overall, the fetal outcome 
came out well with 34 (64.2%) live births, despite there was 
10 (18.9%) cases of spontaneous abortions. The most frequent 
neonatal complications were preterm delivery (29.4%) and 
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low birth weight (41.2%). Growth retardation was rare, only 
occurred in one live-birth and there was no Neonatal Lupus 
Erythematosus (NLE) and Congenital Heart Block (CHB) 
were recorded. Although pregnancy is not contraindicated 
for patients with SLE, significant fetal, neonatal and maternal 
risks still exist.13 
In the past, pregnancy of lupus patients had high risks of 
complication due to the high flare-up rate especially during the 
late pregnancy or postpartum period. It was also concordance 
with the increased incidences of fetal loss, spontaneous 
abortions, preterm delivery and intrauterine death.5,1426 
patients Our study and several recent studies had shown 
an increase morbidity rate in pregnancies of lupus patients 
compared to healthy women. 
A study was conducted by Hee WC in Mackay Memorial 
Hospital, Taipei, Taiwan with 24 pregnancies in 17 female SLE 
patients between January 2000 and February 2005,5 revealed 
22 (91.6%) live-birth pregnancies, eight (33.3%) preterm 
delivery,5 two (8.3%) pregnancies were terminated due to loss 
of fetal heartbeat, three (13.6%) of the neonates had IUGR, 
and one (4.5%) had stillbirth.5 Pre-eclampsia occurred in three 
(13.6%) subjects. 5 There is no symptom indicating disease 
flare-up throughout the pregnancy period, such as malar rash, 
alopecia, and arthritis.5 
A prospective study conducted by Aly Eman in the 
high-risk pregnancy unit in Department of Obstetrics and 
Gynecology, Cairo University Hospitals, Egypt included 84 
SLE patients for the total 91 pregnancies from October 2010 
to January 2015,15 showed complications such as arthritis 
were experienced by 84 (92%) patients, hypertension in 36 
(39%) patients; hematological abnormalities (anemia and 
thrombocytopenia) were presented in 39 (42%) patients;15 
spontaneous abortion occurred in 14 patients (15%), 7 (8%) 
pregnancies had IUFD, 3 (3%) cases of neonatal death and 77 
(76%) live births neonates; 15 Twenty-nine (32%) pregnancies 
had IUGR, 12 (13%) was recorded with preterm deliveries, 
12 (13%) experienced pre-eclampsia during pregnancy and 20 
(22%) neonates presented with low birth weight. 15 
There was another study conducted by Dey ID at the 
Korle-bu Teaching Hospital in 2013 in Ghana, West Africa 
showed that out of 7 pregnancies, there were 4 cases of full 
term birth and 3 cases were loss births during 16, 24 and 
32 weeks of pregnancy.16 Meanwhile, six of these patients 
complained of arthritis, three had hypertension, four had 
rash. But no maternal death were reported. 16 Many doctors 
in Ghana did not have experience managing pregnant SLE 
patients. Thus, most pregnancies were not planned with the 
physicians.16 However, these cases provide valuable evidence 
that normal pregnancy is possible within SLE patients, even in 
poor resource settings.16 
Upon the results, SLE remained stable in most patients 
during their pregnancy. Most women were able to carry out 
their pregnancy to term with a mild lupus activity.5 Hence, 
mothers with active SLE would achieve a higher chance to 
deliver successful pregnancies if they got optimal care from 
obstetricians and physicians.5,17
Every woman with SLE who would like to get pregnant 
should consult and make plan with their respective 
physicians in order to decrease the risk of fetal and maternal 
complications. Patients are suggested to conceive only 
when the disease is inactive or has been stable for 6 months 
on appropriate medications.16 Pre-pregnancy counseling 
and multidisciplinary management can crucially improve 
the maternal and fetal outcome in lupus pregnancies.16 
Throughout the gestational period, patients should cooperate 
with the physicians for detailed monitoring and antenatal 
care. Furthermore, some people experienced exacerbations 
of the disease in the postpartum period. Mother with SLE 
after pregnancy should be giving a great care and undergo 
respective management as to decrease or prevent any flares.
Limitation of this study is the time to conduct the 
research, due to that we only managed to get 53 samples out 
of 96 minimal required samples. The data only based on the 
interview, pediatrician and obstetrician were not involved 
to validate. Furthermore, our results were limited by the 
incomplete medical record about the manifestations during 
delivery such as laboratory results.
Conclusion 
In conclusion, the most frequent maternal complications 
during pregnancy were arthritis and rash. Pre-eclampsia and 
placenta previa were the most frequent obstetric complications 
which experienced by the pregnant SLE patients. Apart from 
live birth, the most frequent fetal outcome was spontaneous 
abortion. The most frequent neonatal complications were 
preterm delivery and low birth weight.
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